Intestinal Beh&ccedil;et&rsquo;s disease appearing during treatment with adalimumab in a patient with ankylosing spondylitis

doi:10.3748/wjg.v19.i32.5389

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 19, Issue 32

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5800)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

319

HTML

3305

Figures (1-2)

117

Tables (1-1)

124

Sum=3865

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

931

Download

1004

Sum=1935

Aug 28, 2013 (publication date) through Apr 28, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastroenterol. Aug 28, 2013; 19(32): 5389-5392
Published online Aug 28, 2013. doi: 10.3748/wjg.v19.i32.5389

Full Size Figure Download Figure

Figure 2 In computed tomography, arrow showed bowel wall thickening and prominent enhancement with surrounding fat infiltration at the terminal ileum and cecum. This was suggestive of active inflammation.

Citation: Chung SH, Park SJ, Hong SP, Cheon JH, Kim TI, Kim WH. Intestinal Behçet’s disease appearing during treatment with adalimumab in a patient with ankylosing spondylitis. World J Gastroenterol 2013; 19(32): 5389-5392
URL: https://www.wjgnet.com/1007-9327/full/v19/i32/5389.htm
DOI: https://dx.doi.org/10.3748/wjg.v19.i32.5389